your lawmakers' votes
at your finger tips
Legislation watch

Search all years.

2017 House Bill 4472: Allow FDA-designated interchangeable biological drugs
Introduced by Rep. John Bizon (R) on March 30, 2017
To allow pharmacists to dispense FDA-designated interchangeable biological drug products.   Official Text and Analysis.
Referred to the House Health Policy Committee on March 30, 2017
Reported in the House on January 17, 2018
With the recommendation that the substitute (H-3) be adopted and that the bill then pass.
Amendment offered by Rep. Hank Vaupel (R) on January 24, 2018
The amendment passed by voice vote in the House on January 24, 2018
Passed 105 to 1 in the House on January 25, 2018.
    See Who Voted "Yes" and Who Voted "No".
(same description)
To allow pharmacists to dispense FDA-designated interchangeable biological drug products.
Received in the Senate on January 30, 2018
Referred to the Senate Health Policy Committee on January 30, 2018
Reported in the Senate on January 31, 2018
With the recommendation that the bill pass.
Passed 34 to 0 in the Senate on February 15, 2018.
    See Who Voted "Yes" and Who Voted "No".
(same description)
To allow pharmacists to dispense FDA-designated interchangeable biological drug products.

Comments